Headlines Covid-19 Specialties Trending Feeds Videos

Severe COVID-19 Outcomes May be Improved With Bevacizumab

posted 3 weeks

Mashup Score: 45

Contagion Live - Findings included a reduction in fever, an increase in white blood cells and a sharp decrease of c-reactive protein (CRP)...

  • "Our findings suggest that #bevacizumab plus standard care is highly beneficial for patients with severe #COVID19 and should be considered as a potential first-line #therapeutic regimen for this group." https://t.co/WgnZmH8KPE

The Lancet Oncology - Continuing bevacizumab beyond progression combined with chemotherapy in patients with platinum-sensitive recurrent ovarian cancer improves progression-free survival compared with standard chemotherapy alone and might...

  • Also new in our Feb issue: #Carboplatin-based doublet plus #bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive #ovariancancer: a randomised, phase 3 trial https://t.co/GUvQW9zePb #gyncsm

Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer

posted 6 days

The Oncologist - The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original...